NEW YORK (GenomeWeb News) — Google has become a minority owner of early-stage personal genomics company 23andMe after investing $3.9 million as part of a Series A round of private-equity financing, Google said in a filing with the US Securities and Exchange Commission today.
 
Other investors in the round include Genentech, New Enterprise Associates, and MDV-Mohr Davidow Ventures. Genentech CEO Arthur Levinson is a Google director.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.